5 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... fluoroquinolone #IDSA ... Regimen #Management #Guidelines ... #pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines ... #Treatment
Paxlovid Drug-Drug Interactions
Before prescribing ritonavir-boosted nirmatrelvir (Paxlovid) for outpatient treatment of COVID-19, determine whether the patient
for outpatient treatment ... of COVID-19, determine ... receiving any of the medications ... files.covid19treatmentguidelines.nih.gov/guidelines ... Interactions #DDI #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... prevent TB disease) Indications ... Adolescent ARV Guidelines ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology